Related Experiment Video

Updated: May 11, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors

Jing Sun1, Daohai Zhang, Dong-Hun Bae

  • 1Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Carcinogenesis
|May 15, 2013
PubMed

Insights

N-myc downstream regulated gene 1 (NDRG1) suppresses cancer metastasis by inhibiting key signaling pathways and cellular processes. This review details NDRG1

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • N-myc downstream regulated gene 1 (NDRG1) is a metastasis suppressor implicated in various neoplasms.
  • Its precise molecular mechanisms in inhibiting cancer progression remain incompletely understood.
  • NDRG1 presents a promising therapeutic target for managing metastatic cancer.

Purpose of the Study:

  • To review and synthesize recent findings on NDRG1's role in cancer metastasis.
  • To elucidate the molecular mechanisms underlying NDRG1's antimetastatic effects.
  • To highlight NDRG1's interactions with critical oncogenic pathways.

Main Methods:

  • Literature review of recent studies on NDRG1 and cancer metastasis.
  • Analysis of NDRG1's interactions with nuclear factor-kappaB (NF-κB), PI3K/AKT/mTOR, and Ras/Raf/MAPK pathways.
  • Examination of NDRG1's effects on epithelial-mesenchymal transition (EMT), TGF-β, and Wnt/β-catenin signaling.
  • Investigation of NDRG1's regulation of molecular motors and cytoskeletal dynamics.

Main Results:

  • NDRG1 negatively impacts tumor progression and metastasis across multiple cancer types.
  • NDRG1 inhibits key oncogenic signaling pathways including NF-κB, PI3K/AKT/mTOR, and Ras/Raf/MAPK.
  • NDRG1 suppresses epithelial-mesenchymal transition (EMT), TGF-β, and Wnt/β-catenin pathways.
  • NDRG1 regulates molecular motors, inhibiting F-actin polymerization and stress fiber formation, thereby reducing cancer cell migration.

Conclusions:

  • NDRG1 exerts potent antimetastatic effects in cancer cells through diverse molecular mechanisms.
  • Understanding these mechanisms provides a foundation for developing NDRG1-based cancer therapies.
  • NDRG1's multifaceted inhibition of cancer cell migration and invasion underscores its therapeutic potential.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...